Centaurus Financial’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-56,999
| Closed | -$2.63M | – | 987 |
|
|
2021
Q4 | $2.63M | Buy |
+56,999
| New | +$2.63M | 0.2% | 137 |
|
|
2021
Q3 | – | Sell |
-26,028
| Closed | -$1.35M | – | 957 |
|
|
2021
Q2 | $1.35M | Buy |
26,028
+23,903
| +1,125% | +$1.24M | 0.11% | 219 |
|
|
2021
Q1 | $107K | Sell |
2,125
-21,946
| -91% | -$1.11M | 0.01% | 769 |
|
|
2020
Q4 | $1.25M | Buy |
24,071
+21,716
| +922% | +$1.13M | 0.13% | 189 |
|
|
2020
Q3 | $102K | Hold |
2,355
| – | – | 0.01% | 623 |
|
|
2020
Q2 | $101K | Buy |
+2,355
| New | +$101K | 0.01% | 597 |
|
|
2020
Q1 | – | Sell |
-14,270
| Closed | -$652K | – | 671 |
|
|
2019
Q4 | $652K | Buy |
+14,270
| New | +$652K | 0.09% | 252 |
|
|
2019
Q1 | – | Sell |
-102
| Closed | -$3 | – | 584 |
|
|
2018
Q4 | $3 | Buy |
102
+99
| +3,300% | +$3 | 0.02% | 384 |
|
|
2018
Q3 | $132 | Sell |
3
-2,707
| -100% | -$119K | 0.02% | 459 |
|
|
2018
Q2 | $117K | Sell |
2,710
-150
| -5% | -$6.48K | 0.02% | 659 |
|
|
2018
Q1 | $120K | Buy |
+2,860
| New | +$120K | 0.03% | 406 |
|